JP2019533644A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533644A5
JP2019533644A5 JP2019514312A JP2019514312A JP2019533644A5 JP 2019533644 A5 JP2019533644 A5 JP 2019533644A5 JP 2019514312 A JP2019514312 A JP 2019514312A JP 2019514312 A JP2019514312 A JP 2019514312A JP 2019533644 A5 JP2019533644 A5 JP 2019533644A5
Authority
JP
Japan
Prior art keywords
composition
combination
permeation enhancer
permeation
sol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019514312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019533644A (ja
JP7277360B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/051577 external-priority patent/WO2018053140A1/en
Publication of JP2019533644A publication Critical patent/JP2019533644A/ja
Publication of JP2019533644A5 publication Critical patent/JP2019533644A5/ja
Application granted granted Critical
Publication of JP7277360B2 publication Critical patent/JP7277360B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019514312A 2016-09-14 2017-09-14 薬物送達のための透過促進剤を有する組成物 Active JP7277360B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662394716P 2016-09-14 2016-09-14
US62/394,716 2016-09-14
PCT/US2017/051577 WO2018053140A1 (en) 2016-09-14 2017-09-14 Compositions with permeation enhancers for drug delivery

Publications (3)

Publication Number Publication Date
JP2019533644A JP2019533644A (ja) 2019-11-21
JP2019533644A5 true JP2019533644A5 (enExample) 2020-11-05
JP7277360B2 JP7277360B2 (ja) 2023-05-18

Family

ID=61619716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019514312A Active JP7277360B2 (ja) 2016-09-14 2017-09-14 薬物送達のための透過促進剤を有する組成物

Country Status (8)

Country Link
US (1) US20200138710A1 (enExample)
EP (1) EP3512501A4 (enExample)
JP (1) JP7277360B2 (enExample)
KR (1) KR20190053215A (enExample)
CN (2) CN109937033A (enExample)
AU (1) AU2017326347B2 (enExample)
CA (1) CA3036696A1 (enExample)
WO (1) WO2018053140A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016304585B2 (en) 2015-08-05 2023-04-06 Children's Medical Center Corporation Compositions with permeation enhancers for drug delivery
WO2022031577A1 (en) * 2020-08-03 2022-02-10 Children's Medical Center Corporation Thermo-sensitive permeation enhancing formulations for drug delivery
EP3949956A1 (en) * 2020-08-06 2022-02-09 LTS Lohmann Therapie-Systeme AG Esketamine-suspension-tts
GB202100945D0 (en) * 2021-01-25 2021-03-10 Brightcure Ltd A composition useful for treating bacterial infections
DE102021132055B4 (de) 2021-10-08 2024-12-12 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung Neue Therapiekonzepte für die Behandlung von Otitis
CN117618338A (zh) * 2022-08-16 2024-03-01 海南普利制药股份有限公司 一种稳定的奥利万星药物水溶液及其制备方法
CN118518439B (zh) * 2023-02-17 2025-09-16 清华大学 离子液体制剂和组织处理方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006597A1 (en) * 1994-08-30 1996-03-07 Alcon Laboratories, Inc. Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
WO2000007603A2 (en) * 1998-08-04 2000-02-17 Madash Llp End modified thermal responsive hydrogels
JP4822652B2 (ja) * 2000-11-22 2011-11-24 エンド ファーマシューティカルズ インコーポレイテッド 粘膜炎の治療
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
WO2009142719A2 (en) * 2008-05-19 2009-11-26 Massachusetts Institute Of Technology Tympanic membrane permeating ear drops and uses thereof
CN106344495A (zh) * 2008-12-22 2017-01-25 奥德纳米有限公司 用于治疗耳部病症的控制释放耳感觉细胞调节剂组合物
AU2016304585B2 (en) * 2015-08-05 2023-04-06 Children's Medical Center Corporation Compositions with permeation enhancers for drug delivery

Similar Documents

Publication Publication Date Title
JP2018522905A5 (enExample)
CN101137359B (zh) 治疗耳感染的方法
US12201622B2 (en) Continuous delivery of lenalidomide and other immunomodulatory agents
JP2023523155A5 (enExample)
BRPI0608690A2 (pt) uso de uma composição antimicrobiana
EP3446692A1 (en) Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
CN101588789B (zh) 用于治疗牛和其它动物炎症的药物组合物和方法
JP2011173928A5 (enExample)
CN113853196B (zh) 长效可注射调配物和其用途
US20250302966A1 (en) Fulvestrant formulations
JP2017031202A (ja) 哺乳動物の内耳及び外耳の感染症の治療に有用な耳科用組成物
BR112019026073B1 (pt) Formulações em gel de nu-3 e usos das mesmas
JP2010195823A (ja) 小動物用の注射可能な獣医用組成物
US20140348959A1 (en) Formulations and Methods for Treating Ear Conditions
US9511077B2 (en) Medical devices and methods comprising an anabolic agent for wound healing
US20140107088A1 (en) Medical devices and methods comprising an anabolic agent for treatment of an injury
PT1811995E (pt) Composição veterinária transmucosa compreendendo detomidina
CA2869377C (en) Fulvestrant formulations
US20200330436A1 (en) Compositions and Methods for Treatment and Prevention of Pyrexia in Horses
TWI649097B (zh) 乙醯胺酚之可注射製劑
JP2005089345A (ja) 虫刺され治療薬
WO2026041786A1 (en) Injectable veterinary composition and uses thereof
US20150141518A1 (en) Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation
JPWO2013125440A1 (ja) 動物向け外皮用製剤